Cents and Sensibility - Kimberly and Friends' Consortium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kimberly Lee who wrote (39942)	12/7/1999 2:04:00 PM
From: JD	of 108040

Bought ILXO @ 17 1. - Positive news released by U of Texas about "Campath" Leukemia treatment - news not appearing under ILXO ticker yet (ILXO owns "Campath") Monoclonal Antibody Appears Effective in Patients With Advanced B-Cell Chronic Lymphocytic Leukemia" "The data showing that CAMPATH appears both effective and relatively safe in patients who have failed all available therapies for their CLL is promising. CAMPATH reversed the course of disease progression or prevented progression in 93 percent of the study patients, and, at one year of follow-up, median survival had not been reached," said Dr. Keating. newsalert.com 2. - CANCER COMPANIES CONVENE IN SEATTLE DEC. 11 TO SHOWCASE SCIENCE, FINANCES AT INVESTORS FORUM Research news should be released under "ILXO" at least by the conference on Sat. Jerry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next